# IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

> **NCT00300586** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 842 (actual)

## Conditions studied

- Stage IV Non-small Cell Lung Cancer

## Interventions

- **DRUG:** observation
- **DRUG:** gemcitabine
- **DRUG:** erlotinib

## Key facts

- **NCT ID:** NCT00300586
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 842 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300586, "IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00300586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*